Vanguard Group Inc. Acquires 1,295,825 Shares of Alignment Healthcare, Inc. $ALHC

Key Points

• Vanguard Group Inc. increased its holdings in Alignment Healthcare, Inc. by 13.2%, now owning approximately 5.62% of the company, valued at $206.9 million after acquiring over 1.2 million shares.
• Insider Joseph S. Konowiecki sold 25,000 shares at an average price of $16.00, while another insider, Hyong Kim, sold 18,600 shares at an average price of $14.54, indicating notable insider selling activity.
• Alignment Healthcare reported a revenue increase of 49% year-over-year with earnings per share of $0.07, surpassing analysts' expectations of a loss, and set an EPS guidance for FY 2025.

Vanguard Group Inc. increased its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 13.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,113,896 shares of the company's stock after purchasing an additional 1,295,825 shares during the period. Vanguard Group Inc. owned 5.62% of Alignment Healthcare worth $206,941,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Teacher Retirement System of Texas raised its position in shares of Alignment Healthcare by 109.1% during the 1st quarter. Teacher Retirement System of Texas now owns 47,447 shares of the company's stock valued at $883,000 after purchasing an additional 24,755 shares during the period. Northern Trust Corp raised its position in shares of Alignment Healthcare by 8.6% during the 4th quarter. Northern Trust Corp now owns 908,964 shares of the company's stock valued at $10,226,000 after purchasing an additional 72,063 shares during the period. New York State Common Retirement Fund raised its position in shares of Alignment Healthcare by 100.9% during the 1st quarter. New York State Common Retirement Fund now owns 165,642 shares of the company's stock valued at $3,084,000 after purchasing an additional 83,187 shares during the period. Victory Capital Management Inc. boosted its position in shares of Alignment Healthcare by 905.7% during the first quarter. Victory Capital Management Inc. now owns 114,397 shares of the company's stock worth $2,130,000 after acquiring an additional 103,022 shares during the last quarter. Finally, GAMMA Investing LLC boosted its position in shares of Alignment Healthcare by 3,216.9% during the first quarter. GAMMA Investing LLC now owns 23,815 shares of the company's stock worth $443,000 after acquiring an additional 23,097 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ALHC. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the stock from $9.00 to $13.00 in a research report on Thursday, July 31st. UBS Group upped their target price on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Alignment Healthcare currently has an average rating of "Moderate Buy" and a consensus price target of $18.56.

Alignment Healthcare Price Performance

ALHC stock traded up $0.04 during trading on Friday, hitting $15.84. 2,885,734 shares of the company's stock traded hands, compared to its average volume of 4,031,600. Alignment Healthcare, Inc. has a 52 week low of $8.65 and a 52 week high of $21.06. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.66 and a current ratio of 1.66. The business has a fifty day simple moving average of $13.77 and a 200 day simple moving average of $15.30. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of -56.57 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's revenue was up 49.0% on a year-over-year basis. During the same period last year, the company earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Christopher J. Joyce sold 15,491 shares of the firm's stock in a transaction on Thursday, July 31st. The stock was sold at an average price of $16.01, for a total value of $248,010.91. Following the completion of the sale, the insider directly owned 374,531 shares in the company, valued at $5,996,241.31. This trade represents a 3.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO John E. Kao sold 180,000 shares of the firm's stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the sale, the chief executive officer owned 1,553,100 shares of the company's stock, valued at approximately $20,827,071. This represents a 10.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 624,153 shares of company stock valued at $9,037,301 over the last 90 days. 7.00% of the stock is currently owned by insiders.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.